Table 4 Association between ZIKV laboratory results, clinical findings, and gestational age at infection.
From: Zika virus vertical transmission in children with confirmed antenatal exposure
Any positive ZIKV-Lab result (N = 84) | Any negative ZIKV-Lab result (N = 46) | |||||
---|---|---|---|---|---|---|
All infants | n | % | n | % | p-Value | |
All infants | 130 | 84 | 65% | 46 | 35% | |
Infants with abnormal findingsa | 45 | 29 | 64% | 16 | 36% | 0.98 |
Infants with no abnormal findingsa | 85 | 55 | 65% | 30 | 35% | |
Brain Imaging | 113 | 74 | 65% | 39 | 35% | 0.37 |
Structural abnormalities | 14 | 11 | 79% | 3 | 21% | |
Fundoscopy | 109 | 68 | 62% | 41 | 38% | 0.41 |
Abnormal | 6 | 5 | 83% | 1 | 17% | |
Hearing Assessment | 91 | 60 | 66% | 31 | 34% | 0.09 |
Abnormal | 11 | 10 | 91% | 1 | 9% | |
Neurologic exam | 130 | 84 | 65% | 46 | 35% | 0.94 |
Abnormal | 25 | 16 | 64% | 9 | 36% | |
Gestational age assessment | 130 | 84 | 65% | 46 | 35% | 0.74 |
Small for gestational age | 10 | 6 | 60% | 4 | 4% | |
Neurodevelopment | 129 | 83 | 64% | 46 | 36% | 0.76 |
Abnormal Bayley-III or HINES | 17 | 12 | 71% | 5 | 29% | |
Gestational Trimester of Infection | 130 | 84 | 65% | 46 | 35% | |
First | 40 | 31 | 78% | 9 | 23% | 0.04 |
Second | 61 | 39 | 64% | 22 | 36% | |
Third | 29 | 14 | 48% | 15 | 52% |